Searched for
LASA DRUGS
Stock market update: Stocks that hit 52-week lows on NSETech Mahindra, SBI Life, ICICI Bank, Eternal and Wipro were among the top losers on NSE.- Stock market update: Nifty Bank index falls 0.17% in a weak marketThe Nifty Bank index was trading 0.17 per cent down at 57071.55.
- Sensex rises! These stocks gained over 10% on BSEIn the Nifty 50 index, 33 stocks ended in the green, while 17 stocks closed in the red in today's trade.
- Look-alike, sounding similar drugs likely to face strict actionEarlier, in January India's Drug Technical Advisory Board (DTAB), India's apex drug advisory body, deliberated on the issue of same brand n...
- Stocks in the news: RIL, Bajaj Finance, Tata Motors, Wipro, HDFC Life and HULHUL, Bajaj Auto, Trent, HDFC AMC, Indian Hotels, Persistent Systems, Syngene International, Hatsun Agro, KPR Mills, IEX and Supreme Petroch...
- Stocks in the news: TCS, Tata Steel, Veranda Learning, Wipro and Tata MotorsTCS, Delta Corp, Birla Tyres, Kesoram Industries, Lasa Supergenerics, Elnet Technologies, Hathway Bhawani Cabletel and MPL Plastics are amo...
- 42 stocks from 2 sectors that doubled money in 2020 still have more steamChart topper Venus Remedies has rallied the most at 546 per cent, followed by Aarti Drugs (up 382 per cent), Mangalam Drugs (375 per cent),...
- Strike when it’s hot! 58% stocks from this sector defy crisis to double pricesThis outperformance came after an underperformance of four years.
- Market Movers: L&T, Lupin, DRL gain; HDFC twins key drag; 50 stocks enter ‘buy’ zoneHDFC twins and Reliance Industries were among the biggest drags, but a jump in L&T after three ‘large’ order wins cushion the fall to some ...
- Lasa Supergenerics jumps 5% on Maha FDA nodThe drug will be manufactured at its WHO GMP certified facility at Mahad Industrial Area.
- Two Mumbai companies step up work on COVID-19 drug helping in recoveryMumbai-based BDR Pharma, which makes anti-HIV and Hepatitis C medication, and LASA Supergenerics, an active pharmaceutical ingredient maker...
- A Mumbai company is working on a potential coronavirus medicineFavipiravir, an off-patent drug originally owned by Japanese drug maker Fuji, holds potential against RNA viruses, one of which is Covid-19...
- Japan drug showing 'favourable' results: ChinaChina's National Centre for Biotechnology development claimed that the drug Favipiravir, developed almost 25 years back, showed 'favourable...
- Coronavirus outbreak: How much testing should we do, and where are we on developing a vaccine?Over 170,000 individuals across the world have been infected by the novel coronavirus and 6,509 have died, with cases and deaths outside Ch...
- Market Movers: Venky's, airline stocks, YES Bank hit hard; 44 stocks flash 'sell' signalsAirline shares fell up to 5 per cent, as travel is getting hit due to the fast spreading disease.
- Market Movers: RITES falls as OFS sails, Axis Bank gains; buy signals in 25 stocksThe BSE flagship shed 143 points to 39,745 while Nifty dipped 45 points to 11,633.
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.
- Market Now: Check out the stocks that cracked over 5%The NSE Nifty index was trading 21 points up at 10,464, while BSE Sensex was 59 points up at 33,853 around 10:05 am (IST).
- Delhi govt to set up cell to train nursesIn the initial stages, the cell will provide training to nurses of government hospitals on prevention of medication errors.
- Omkar Chemicals to invest Rs 100 crore in Chiplun facilityOmkar Speciality Chemicals will set up a new facility for speciality chemicals with an estimated investment to the tune of Rs 100 crore at ...
Load More
